Glucose in the hypothalamic paraventricular nucleus regulates GLP-1 release

JCI Insight. 2020 Mar 31;5(8):e132760. doi: 10.1172/jci.insight.132760.

Abstract

Glucokinase (GK) is highly expressed in the hypothalamic paraventricular nucleus (PVN); however, its role is currently unknown. We found that GK in the PVN acts as part of a glucose-sensing mechanism within the PVN that regulates glucose homeostasis by controlling glucagon-like peptide 1 (GLP-1) release. GLP-1 is released from enteroendocrine L cells in response to oral glucose. Here we identify a brain mechanism critical to the release of GLP-1 in response to oral glucose. We show that increasing expression of GK or injection of glucose into the PVN increases GLP-1 release in response to oral glucose. On the contrary, decreasing expression of GK or injection of nonmetabolizable glucose into the PVN prevents GLP-1 release. Our results demonstrate that gluco-sensitive GK neurons in the PVN are critical to the response to oral glucose and subsequent release of GLP-1.

Keywords: Diabetes; Endocrinology; Glucose metabolism; Neuroscience; Peptides.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Glucagon-Like Peptide 1 / genetics*
  • Glucokinase / metabolism
  • Glucose / pharmacology*
  • Male
  • Paraventricular Hypothalamic Nucleus / metabolism*
  • Rats
  • Rats, Inbred WF

Substances

  • Glucagon-Like Peptide 1
  • Glucokinase
  • Glucose